To determine whether DGAT1 was a common enzyme utilized by other tumor cell types, we used the same DGAT1 inhibitor treatment regimen and found a similar effect in reducing the proliferative rate in both pancreatic cancer cells (PANC-1) (PANC-1 DGAT1 in. Here, DGAT1 is linked to familial pancreatic carcinoma.